Medical hypothesis discovery and innovation in ophthalmology

Punctate Inner Choroidopathy: A Systematic Review

Medical hypothesis discovery and innovation in ophthalmology, Vol. 3 No. 3 (2014), 1 September 2014 , Page 76-82

Abstract

This article reviews clinically relevant data regarding punctate inner choroidopathy, mainly the various treatment options. Punctate inner choroidopathy is an uncommon, inflammatory, multifocal chorioretinopathy affecting mostly young myopic women. It is characterized by the presence of multiple, small, well-defined, yellow-white fundus lesions, in the absence of intraocular inflammation. We describe etiology, clinical findings and ancillary tests that help in the diagnosis and detection of complications. Treatment options that have been used to manage patients with PIC and CNV include immunosuppressants, corticoids, laser photocoagulation, photodynamic therapy, intravitreal anti-VEGF agents and submacular surgery.

References

Watzke RC, Packer AJ, Folk JC, Benson WE, Burgess D, Ober RR. Punctate inner choroidopathy. Am J Ophthalmol. 1984 Nov;98(5):572-84. PMID: 6208783.

American Academy of Ophtalmology, The Eye M.D. Association: Focal and Diffuse Choroidal and Retinal Inflammation; in Basic and Clinical Science Course, section 12: Retina and Vitreous. Leo; 2011-2012.

Channa R, Ibrahim M, Sepah Y, Turkcuoglu P, Lee JH, Khwaja A, Hatef E, Bittencourt M, Heo J, Do DV, Nguyen QD. Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography. J Ophthalmic Inflamm Infect. 2012 Sep;2(3):113-20. PMID: 22210152

Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, Jabs DA, Nguyen QD: Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology. 2007 Jun;114(6):1201-4. PMID: 17434588

Olsen TW, Capone A, Sternberg P Jr, Grossniklaus HE, Martin DF, Aaberg TM Sr. Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology. 1996 Dec;103(12):2061-9. PMID: 9003340

Brouzas D, Charakidas A, Rotsos T, Moschos MM, Loukianou H, Koutsandrea C, Ladas I, Baltatzis S. Choroidal neovascularization due to punctuate inner choroidopathy: long-term follow-up and review of literature. Clin Ophthalmol. 2010 Aug 9;4:871-6. PMID: 20714365

Turkcuoglu P, Chang PY, Rentiya ZS, Channa R, Ibrahim M, Hatef E, Sophie R, Sadaka A, Wang J, Sepah YJ, Do DV, Foster CS, Nguyen QD. Mycophenolate Mofetil and Fundus Autofluorescence in the Management of Recurrent Punctate Inner Choroidopathy. Ocul Immunol Inflamm. 2011 Aug;19(4):286-92. PMID: 21770809

Levy J, Shneck M, Klemperer I, Lifshitz T: Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature. Can J Ophthalmol. Oct 2005;40(5):605-8. PMID: 16391624

Chan WM, Lai TY, Lau TT, Lee VY, Liu DT, Lam DS. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series. Retina. 2008 Jan;28(1):71-80. PMID: 18185141

Valverde Megías A, Arriola Villalobos P, Reche Frutos J, Donate López J, Calvo González C, García Feijoo J. Intravitreal ranibizumab (Lucentis®) in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy. Arch Soc Esp Oftalmol. 2010 Apr;85(4):149-52. PMID: 20858403

Mangat SS, Ramasamy B, Prasad S, Walters G, Mohammed M, Mckibbin M. Resolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal anti-VEGF agents: a case series. Semin Ophthalmol. 2011 Jan;26(1):1-3. PMID: 21275596

Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol. 2007 Jun;143(6):977-983. PMID: 17459318

Jampol LM, Becker KG. White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease. Am J Ophthalmol 2003;135:376–9. PMID: 12614757

Hirooka K, Saito W, Hashimoto Y, Saito M, Ishida S. Increased macular choroidal blood flow velocity and decreased choroidal thickness with regression of punctate inner choroidopathy. BMC Ophthalmol. 2014 May 28;14:73. PMID: 24885365

Essex RW, Wong J, Fraser-Bell S, Sandbach J, Tufail A, Bird AC, Dowler J. Punctate inner choroidopathy: clinical features and outcomes. Arch Ophthalmol. 2010 Aug;128(8):982-7. PMID: 20696997

Brown J, Folk JC, Reddy CV, Kimura AE. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology. 1996;103:1100-5. PMID: 8684800

Campos J, Campos A, Beselga D, Mendes S, Neves A, Sousa JP. Punctate Inner Choroidopathy: A Clinical Case Report. Case Rep Ophthalmol. 2013 Sep 28;4(3):155-9. PMID: 24163685

Amer R, Lois N. Punctate Inner Choroidopathy. Surv Ophthalmol. 2011 Jan-Feb;56(1):36-53. PMID: 21056447

Patel KH, Birnbaum AD, Tessler HH, Goldstein DA. Presentation and outcome of patients with punctate inner choroidopathy at a tertiary referral center. Retina. 2011;31(7):1387-91. PMID: 21478811

Zarranz-Ventura J, Sim DA, Keane PA, Patel PJ, Westcott MC, Lee RW, Tufail A, Pavesio CE. Characterization of Punctate Inner Choroidopathy Using Enhanced DepthImaging Optical Coherence Tomography. Ophthalmology. 2014 Sep;121(9):1790-7. PMID: 24856311

Tiffin PA, Maini R, Roxburgh ST, Ellingford A. Indocyanine green angiography in a case of punctate inner choroidopathy. Br J Ophthalmol. 2002;80(1):90-1. PMID: 8664243

Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ. The use of corticosteroids for choroidal neovascularisation in young patients. Eye (Lond). 1998;12 ( Pt 2):266-72. PMID: 9683952

Brueggeman RM, Noffke AS, Jampol L. Resolution of punctate inner choroidopathy lesions with oral prednisone therapy. Arch Ophthalmol 2002;120(7):996. PMID: 12096982

Leung A, Weisbrod D, Schwartz C. Intravitreal ranibizumab in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy. Can J Ophthalmol. 2010 Jun;45(3):300-1. PMID: 20379284

Menezo V, Cuthbertson F, Downes SM. Positive responseto intravitreal ranibizumab in the treatment of choroidalneovascularization secondary to punctate innerchoroidopathy. Retina. 2010 Oct;30(9):1400-4. PMID: 20224465

Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Retina. 2011 May;31(5):871-9. PMID: 21358461

Zhang H, Liu ZL, Sun P, Gu F. Intravitreal bevacizumab as primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy: results of a 1-year prospective trial. Retina. 2012 Jun;32(6):1106-13. PMID: 22481479

Jiménez B, Pinilla I, Cristóbal JA, Mínguez E, Pérez D, Cruz N, Peiro C. Intravitreal ranibizumab in the treatment of subretinal neovascularization in a case of punctate inner choroidopathy. Arch Soc Esp Oftalmol. 2014 Mar;89(3):130-2. PMID: 24269388

Postelmans L, Pasteels B, Coquelet P, Caspers L, Verougstraete C, Leys A, Wirix M, Mauget-Faÿsse M, Quanranta M, Snyers B, Smets E. Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like). Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):361-6. PMID: 16419421

Coco RM, de Souza CF, Sanabria MR. Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy. Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):27-9. PMID: 17365803

  • Abstract Viewed: 2726 times
  • Full Text PDF Downloaded: 2923 times

Download Statastics

Open Journal Systems
Current Issue
Information